USPTO Examiner RAYMOND KEITH MICHAEL - Art Unit 3798

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18774966CRYOPUMPJuly 2024March 2026Allow2000YesNo
18593121SYSTEMS, DEVICES, AND METHODS FOR NON-INVASIVE IMAGE-BASED PLAQUE ANALYSIS AND RISK DETERMINATIONMarch 2024February 2026Allow2410NoNo
18592081SYSTEMS, DEVICES, AND METHODS FOR NON-INVASIVE IMAGE-BASED PLAQUE ANALYSIS AND RISK DETERMINATIONFebruary 2024December 2025Allow2110YesNo
18592176SYSTEMS, DEVICES, AND METHODS FOR NON-INVASIVE IMAGE-BASED PLAQUE ANALYSIS AND RISK DETERMINATIONFebruary 2024January 2026Allow2210NoNo
18556031DEVICE AND METHOD FOR PRE-COOLING A STREAM OF A TARGET FLUID TO A TEMPERATURE LESS THAN OR EQUAL TO 90 KOctober 2023March 2026Abandon2910NoNo
18373052INSTALLATION AND PROCESS FOR PRODUCTION OF A CRYOGENIC FLUIDSeptember 2023February 2026Allow2910NoNo
18276803Device for Providing Liquid Helium Forced Flow Cooling FluidAugust 2023January 2026Abandon2910NoNo
18225243APPARATUS FOR INPUTTING COMBINED IMAGE OF PHOTOACOUSTIC IMAGE AND ULTRASONIC IMAGE AND METHOD THEREOFJuly 2023February 2026Allow3120NoNo
18355347CRYOGENIC LINKJuly 2023October 2025Allow2710YesNo
18267932DEVICE, METHOD AND SYSTEMS FOR PROVIDING IMAGING OF ONE OR MORE ASPECTS OF BLOOD PERFUSIONJune 2023November 2025Allow2910NoNo
18210740Method of Hydrogen Liquefaction Using Optimized Claude Refrigeration CyclesJune 2023September 2025Allow2710NoNo
17839456ULTRASONIC ENDOSCOPE AND BALLOONJune 2022January 2026Abandon4330YesNo
17737287MICROBUBBLE DESTRUCTION FOR MEDICAL ULTRASOUND IMAGINGMay 2022January 2026Allow4450YesNo
17370325Heart Rate Correction Using External DataJuly 2021September 2025Abandon5030NoNo
17332056DETECTING HEART RATES USING EYE-TRACKING CAMERASMay 2021September 2025Abandon5130YesNo
17178403IMAGE PROCESSING APPARATUS, IMAGE PROCESSING METHOD, AND NON-TRANSITORY COMPUTER-READABLE MEDIUMFebruary 2021December 2025Allow5750YesNo
16729313FLEXIBLE MULTI-COIL TRACKING SENSORDecember 2019November 2025Allow6041YesYes
14134634SYSTEM FOR OFFSHORE LIQUEFACTIONDecember 2013January 2014Allow100NoNo
14035642METHOD FOR OFFSHORE LIQUEFACTIONSeptember 2013November 2013Allow100NoNo
13848002METHOD FOR LIQUEFACTION OF NATURAL GAS OFFSHOREMarch 2013October 2013Allow710NoNo
12682673PROCESS FOR THE SEPARATION OF CO2 FROM A GASEOUS FEED STREAMJuly 2010June 2013Allow3820NoNo
12529784Configurations And Methods For Offshore LNG Regasification And Heating Value ConditioningSeptember 2009November 2013Allow5140NoNo
12401875ROTARY TYPE ULTRALOW TEMPERATURE REFRIGERANT SUPPLY APPARATUSMarch 2009January 2014Allow5830YesNo
12307885SHUTTLE TYPE MAGNETIC REFRIGERATORFebruary 2009March 2013Allow5020NoNo
11579320Acoustic Power Transmitting Unit for Thermoacoustic SystemsJuly 2008October 2013Allow6030NoNo
11875052SYSTEM TO COLD COMPRESS AN AIR STREAM USING NATURAL GAS REFRIGERATIONOctober 2007September 2013Allow6040YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner RAYMOND, KEITH MICHAEL.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
21.5%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
1
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
1
(100.0%)
Filing Benefit Percentile
11.4%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner RAYMOND, KEITH MICHAEL - Prosecution Strategy Guide

Executive Summary

Examiner RAYMOND, KEITH MICHAEL works in Art Unit 3798 and has examined 13 patent applications in our dataset. With an allowance rate of 84.6%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 51 months.

Allowance Patterns

Examiner RAYMOND, KEITH MICHAEL's allowance rate of 84.6% places them in the 60% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by RAYMOND, KEITH MICHAEL receive 2.62 office actions before reaching final disposition. This places the examiner in the 77% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by RAYMOND, KEITH MICHAEL is 51 months. This places the examiner in the 5% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a -7.5% benefit to allowance rate for applications examined by RAYMOND, KEITH MICHAEL. This interview benefit is in the 4% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 27.3% of applications are subsequently allowed. This success rate is in the 47% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 4% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 21% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.